Suppr超能文献

长期使用羟丙甲纤维素眼用植入剂缓解配戴隐形眼镜者干眼症状:病例报告。

Long-term use of hydroxypropyl cellulose ophthalmic insert to relieve symptoms of dry eye in a contact lens wearer: case-based experience.

机构信息

Department of Ophthalmology, University of Cincinnati College of Medicine and Academic Health Center, Cincinnati, OH, USA.

出版信息

Eye Contact Lens. 2011 Jan;37(1):39-44. doi: 10.1097/ICL.0b013e3181f84f92.

Abstract

OBJECTIVES

To report a case in which hydroxypropyl cellulose ophthalmic inserts were successfully used for the treatment of dry eye disease in a contact lens (CLs) wearer for more than 25 years.

METHODS

Review of clinical findings in a female CL wearer with dry eye spanning more than 30 years. The patient was diagnosed with the Sjögren syndrome and demonstrated inadequate lacrimation as assessed by Schirmer testing. Slitlamp examination demonstrated bilateral corneal stippling with fluorescein and signs of superior limbic keratoconjunctivitis.

RESULTS

Initially, the patient's symptoms improved with infrequent use of artificial tears. As the signs and symptoms of dry eye disease worsened, the patient initiated therapy with once-daily hydroxypropyl cellulose ophthalmic inserts. Punctal plugs and updating to increasingly oxygen-permeable soft CLs, in combination with continued use of the inserts, largely controlled the signs and symptoms of dry eye disease during a 25-year period. Simultaneous use of the hydroxypropyl cellulose ophthalmic inserts and CLs was well tolerated without any significant side effects or changes in visual acuity.

CONCLUSIONS

Dry eye is a chronic disease often requiring long-term management. In this case, daily use of hydroxypropyl cellulose ophthalmic inserts effectively treated autoimmune dry eye, providing symptomatic relief, and resulted in improved objective measures of disease severity across several decades. Such an experience is consistent with the available evidence-based data for hydroxypropyl cellulose ophthalmic inserts and supports their use in clinical practice for the treatment of moderate-to-severe dry eye disease.

摘要

目的

报告 1 例羟丙基纤维素眼用植入剂成功治疗软性隐形眼镜(CL)佩戴者干眼症超过 25 年的病例。

方法

回顾 1 例患有干眼症超过 30 年的女性 CL 佩戴者的临床发现。该患者被诊断为干燥综合征,泪液分泌不足(通过 Schirmer 测试评估)。裂隙灯检查显示双侧角膜点状染色,荧光素染色阳性,并有上睑缘性角结膜炎的迹象。

结果

最初,患者的症状通过偶尔使用人工泪液得到改善。随着干眼症状和体征的恶化,患者开始每天使用羟丙基纤维素眼用植入剂进行治疗。使用泪点塞和更新更透气的软性 CL,并结合持续使用植入剂,在 25 年的时间里,大部分控制了干眼的症状和体征。羟丙基纤维素眼用植入剂和 CL 同时使用耐受性良好,无明显副作用,也未影响视力。

结论

干眼症是一种慢性疾病,常需长期管理。在本例中,每天使用羟丙基纤维素眼用植入剂有效治疗了自身免疫性干眼症,缓解了症状,并在几十年的时间里改善了疾病严重程度的客观指标。这种经验与羟丙基纤维素眼用植入剂的现有循证数据一致,并支持其在临床实践中用于治疗中重度干眼。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验